Complete Remission of Metastatic Duodenal Neuroendocrine Carcinoma Treated with Chemotherapy and Surgical Resection
The Korean Journal of Pancreas and Biliary Tract. 2019;24(3):121-126 
Surgical resection of primary tumor is prolonged survival in metastatic pancreatic neuroendocrine carcinoma
Annals of Oncology. 2018;29:viii473
Complete Remission of a Metastatic Pancreatic Carcinoma after Modified G-FLIP Therapy
Chemotherapy. 2007;53(5):356-359
Surgical resection of primary tumor site is associated with prolonged survival in metastatic pancreatic neuroendocrine carcinoma
Annals of Oncology. 2018;29:v35
Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda®) monotherapy
Cancer Chemotherapy and Pharmacology. 2007;61(2):347-348
A case of long-term recurrence-free poorly differentiated neuroendocrine carcinoma of lymph nodes treated by surgical resection without any chemotherapy
International Journal of Clinical Oncology. 2010;15(5):493-496
Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection
Surgical Endoscopy. 2022;
Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma
European Journal of Surgical Oncology (EJSO). 2007;33(10):1209-1210
A Case of Duodenal Neuroendocrine Carcinoma Treated with Amrubicin as Second-line Chemotherapy
Journal of Gastrointestinal and Liver Diseases. 2015;24(3):379-382
Response to Letter to Editor: Advances in Endoscopic Techniques for Resection of Duodenal Neuroendocrine Tumours Response to: Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature
Journal of Gastrointestinal Surgery. 2019;23(6):1288-1289